{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:02:47Z","timestamp":1773835367071,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T00:00:00Z","timestamp":1366070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12282-013-0466-2","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T08:58:57Z","timestamp":1366016337000},"page":"643-650","source":"Crossref","is-referenced-by-count":32,"title":["Clinicopathological features of young patients (&lt;35\u00a0years of age) with breast cancer in a Japanese Breast Cancer Society supported study"],"prefix":"10.1007","volume":"21","author":[{"given":"Akemi","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"466_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyr184","volume":"42","author":"T Matsuda","year":"2012","unstructured":"Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2012;42:139\u201347.","journal-title":"Jpn J Clin Oncol"},{"issue":"20","key":"466_CR2","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324\u201330.","journal-title":"J Clin Oncol"},{"key":"466_CR3","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.21070","volume":"103","author":"AM Gonzalez-Angulo","year":"2005","unstructured":"Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, et al. Women age <35 years with primary breast carcinoma disease features at presentation. Cancer. 2005;103:2466\u201372.","journal-title":"Cancer"},{"key":"466_CR4","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1200\/JCO.2006.10.3754","volume":"25","author":"SH Ahn","year":"2007","unstructured":"Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, et al. Poor outcome of hormone receptor positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-A report from the Korean Breast Cancer Society. J Clin Oncol. 2007;25:2360\u20138.","journal-title":"J Clin Oncol"},{"key":"466_CR5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(00)02292-3","volume":"27","author":"S Aebi","year":"2000","unstructured":"Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Th\u00fcrlimann B, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet. 2000;27:1869\u201374.","journal-title":"Lancet"},{"issue":"2","key":"466_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdf039","volume":"13","author":"M Colleoni","year":"2002","unstructured":"Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, et al. Very young women (<35\u00a0years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002;13(2):273\u20139.","journal-title":"Ann Oncol"},{"key":"466_CR7","doi-asserted-by":"crossref","unstructured":"Pronzato P, Mustacchi G, DeMatteis A, Di Costanzo F, Rulli E, Floriani I, et al. Biological characteristics and medical treatment of breast cancer in young women\u2014a featured population: results from the nora study. Int J Breast Cancer. 2011, Article ID 534256, doi: 10.4061\/2011\/534256 .","DOI":"10.4061\/2011\/534256"},{"key":"466_CR8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0959-8049(97)10036-3","volume":"34","author":"O Pagani","year":"1998","unstructured":"Pagani O, O\u2019Neill A, Castiglione M, et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer. 1998;34:632\u201340.","journal-title":"Eur J Cancer"},{"key":"466_CR9","unstructured":"The Japanese breast cancer society. General roles for clinical and pathological recording of breast cancer.16th ed. Histological Classification of breast tumors. Tokyo: The Japanese breast cancer society; 2008. 18\u201359."},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcp\/78.6.806","volume":"78","author":"The World Health Organization","year":"1982","unstructured":"The World Health Organization. World Health Organization histological typing of breast tumors. Am J Clin Pathol. 1982;78:806\u201316.","journal-title":"Am J Clin Pathol"},{"key":"466_CR11","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474\u201381.","journal-title":"J Clin Oncol"},{"key":"466_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2325\/jbcs.13.232","volume":"13","author":"S Umemura","year":"2006","unstructured":"Umemura S, Kurosumi M, Moriya T, Oyama T, Arihiro K, Yamashita H, et al. Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast cancer. 2006;13:232\u20135.","journal-title":"Breast cancer"},{"issue":"10","key":"466_CR13","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00268-010-0683-1","volume":"34","author":"SP Leong","year":"2010","unstructured":"Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western Countries? World J Surg. 2010;34(10):2308\u201324.","journal-title":"World J Surg"},{"key":"466_CR14","unstructured":"Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER cancer statistics review, 1975\u20132009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/ , based on November 2011 SEER data submission, posted to the SEER web site, 2012."},{"issue":"8","key":"466_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jjco\/hyh076","volume":"34","author":"M Yoshimoto","year":"2004","unstructured":"Yoshimoto M, Tada K, Hori H, Morota A, Tanabe M, Nishimura S, et al. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001-an institutional review. Jpn J Clin Oncol. 2004;34(8):457\u201362.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"466_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10147-007-0728-0","volume":"13","author":"T Saeki","year":"2008","unstructured":"Saeki T, Sano M, Komoike Y, Sonoo H, Honjyo H, Ochiai K, et al. No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan. Int J Clin Oncol. 2008;13(1):8\u201311.","journal-title":"Int J Clin Oncol"},{"key":"466_CR17","unstructured":"http:\/\/www.mhlw.go.jp\/topics\/bukyoku\/kenkou\/seikatu\/himan\/number.html ."},{"issue":"10","key":"466_CR18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J, Takayama S, Kamata H, Sekiguchi I, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci. 2008;99(10):1967\u201376.","journal-title":"Cancer Sci"},{"issue":"4","key":"466_CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00432-011-1141-7","volume":"138","author":"YX Shi","year":"2012","unstructured":"Shi YX, Xia Q, Peng RJ, Yuan ZY, Wang SS, An X, et al. Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. J Cancer Res Clin Oncol. 2012;138(4):705\u201314.","journal-title":"J Cancer Res Clin Oncol"},{"key":"466_CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12282-009-0113-0","volume":"17","author":"H Iwase","year":"2010","unstructured":"Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, et al. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer. 2010;17:118\u201324.","journal-title":"Breast Cancer"},{"issue":"1","key":"466_CR21","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1200\/JCO.2010.28.9199","volume":"29","author":"CK Anders","year":"2011","unstructured":"Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol. 2011;29(1):e18\u201320.","journal-title":"J Clin Oncol"},{"key":"466_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12282-011-0308-z","volume":"19","author":"S Saji","year":"2012","unstructured":"Saji S, Hiraoka M, Tokuda Y, Fukui N, Ikeda T. Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004\u20132009. Breast Cancer. 2012;19:1\u20133.","journal-title":"Breast Cancer"},{"issue":"3","key":"466_CR23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10549-012-2156-8","volume":"135","author":"RA Freedman","year":"2012","unstructured":"Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL. Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat. 2012;135(3):893\u2013906.","journal-title":"Breast Cancer Res Treat"},{"key":"466_CR24","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","volume":"23","author":"AU Buzdar","year":"2005","unstructured":"Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al. Significantly higher pathologic complete remissionrate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factorreceptor 2-positive operable breast cancer. J Clin Oncol. 2005;23:3676\u201385.","journal-title":"J Clin Oncol"},{"issue":"3","key":"466_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1470-2045(11)70033-X","volume":"12","author":"L Gianni","year":"2011","unstructured":"Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, et al. Treatment with trastuzumab for 1\u00a0year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol. 2011;12(3):236\u201344.","journal-title":"Lancet Oncol"},{"key":"466_CR26","author":"M Wong","year":"2012","unstructured":"Wong M, O\u2019Neill S, Walsh G, Smith IE. Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes. Ann Oncol. 2012;. doi: 10.1093\/annonc\/mds250 (First published online: September 27).","journal-title":"Ann Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0466-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-013-0466-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0466-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T12:40:53Z","timestamp":1559565653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-013-0466-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s12282-013-0466-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}